Nanomedicine is an interdisciplinary discipline that combines nanoscience, nanoengineering, and nanotechnology with the biological sciences. Given the enormous reach of nanomedicine, we anticipate that it will eventually encompass all fields of medicine. Furthermore, nanomedicine, like medicine, can enter clinics and become a part of standard clinical practise if all aspects of translation are met, including safety, regulatory, and ethical standards. Nanomedicine is predicted to result in the creation of improved devices, medications, and other applications for the early diagnosis or treatment of a wide variety of diseases with high specificity, effectiveness, and personalisation, with the goal of improving patients' quality of life.

In addition to employing nanomedicine to detect and cure illnesses, it is critical to prove the efficacy and safety of nanoparticles in biological systems. What happens to the carrier particle once the medicine has been given or the tissue photographed after the NP has performed as intended following delivery into the body? The particles might be eliminated by renal or hepatobiliary clearance. If they are not cleansed, the NPs' long-term destiny is unknown. Because these particles are small enough to pass through the kidney's filtration slits, they may degrade and be cleared renally, or they may accumulate in different organs and interact with off-target cells.

Nanomedicine is not restricted to colloidal materials and tools for testing them in vivo. Nanomedicine advancements go beyond the notion of a "magic particle bullet."Nanomedicine might entail the development of novel scaffolds and surfaces for designing sensors, as well as implantable systems and electronics to help in tissue regeneration (i.e., regenerative medicine). Many of these ideas are still in the early phases of development, while some are now in clinical use.

Computed Tomography

In human applications, X-ray-based imaging offers high-resolution anatomical and, in the case of CT, three-dimensional (3D) imaging of predominantly skeletal tissues at limitless depth. Because of the simplicity of the technology, the comparably modest demands on infrastructure, the speedy picture generation, and the cheap prices for a basic examination, computed tomography imaging is the workhorse in clinical diagnostics.

Magnetic Resonance Imaging

Because of its safety, spatial resolution, soft tissue contrast, clinical significance, and capacity to capture anatomical and functional information about soft tissues and organs, magnetic resonance imaging is frequently employed for in vivo applications. Notably, MRI-responsive contrast chemicals supplement conventional anatomical pictures with physiological information. MRI does not require ionizing radiation and has an unlimited depth of penetration and unparalleled soft tissue contrast because it is based on the interaction of nuclei with surrounding molecules in a magnetic field. However, in comparison to nuclear and optical modalities, MRI has relatively low sensitivity, resulting in longer acquisition times and the use of large amounts of contrast agents.

Fluorescence Imaging

Fluorescence imaging is advantageous because the emission of probes after excitation may be seen with the naked eye or at higher resolution using optical microscopy. There are several fluorophores available that can be customised to certain uses. Many classic organic fluorophores exhibit aggregation-caused quenching (ACQ), restricting design strategies in which particular interactions increase fluorophore localisation. This has required researchers to employ dilute fluorophores solutions (typically at the nanomolecular level). Because of the little quantity of fluorophore, they are readily photobleached, limiting the possible contrast. Unlike ACQ, aggregation-induced emission (AIE) occurs when higher aggregation results in a brighter fluorescent signal.

Biological Cell-Based Implants

Implants used in regenerative medicine can also be biological in nature. Cell-based therapeutics have enormous promise. Stem cells, for example, when supplied to wounded tissue, have the capacity to rebuild faulty tissue. However, one general challenge with cell-based therapy is that individually delivered cells have short retention durations in the target region. Cells can be delivered in already connected form (so-called cell patches), or they can be seeded into matrices with high binding affinity to improve retention times. Treatment based on connected cell patches rather than isolated cells may thus provide significant advantages.

Toward Artificial Organs

A pressing need in medicine is the in vitro creation of entire organs to solve the issue of organ donor shortages. Nanotechnology is developing as a potent technique that can assist in the fabrication of artificial organs for regenerative medicine as well as organs-on-a-chip applications, which can help to meet this requirement. The capacity of cells to recognise nanoscale objects in their surroundings drives the demand for nanoscale architecture. Many ECM molecules that surround cells, in particular, generate nanofibrous structures that aid in the organisation of cellular architecture and the induction of directed migration and alignment.  As mentioned in the case of implants, one method for engineering such nanoscale structures is to create 3D-fibrous scaffolds.

Nanotechnology letters is an Open-access, peer-reviewed academic journal that aims to publish the most complete and reliable source of information on discoveries and current developments in all areas of the field in the form of original articles, review articles, case reports, short communications, and so on, and to make them available online to researchers worldwide without any restrictions or other subscriptions.

Manuscript Submission

Nanotechnology Letters accepts manuscript submissions through Online Submissions

About the Journal > Online Submissions

Domain: nanolett@eventsupporting.org